Filler Brand Distribution (Number of Injection Sites) of the 41,775 Cases (58,533 Sites) Treated With Hyaluronic Acid Filler Injection
| . | Filler . | |||||
|---|---|---|---|---|---|---|
| Injection site . | Juvéderm Vista Ultra Plus XC . | Juvéderm Vista Volbella XC . | Juvéderm Vista Volift XC . | Juvéderm Vista Voluma XC . | Juvéderm Vista Volux XC . | TOTAL (sites) . |
| Nasolabial fold | 9,422 (54.9%) | 283 (4.8%) | 7,404 (57.5%) | 5,900 (29.2%) | 38 (1.6%) | 23,047 (39.4%) |
| Cheek | 2,543 (14.8%) | 64 (1.1%) | 1,292 (10.0%) | 6,235 (30.9%) | 283 (12.0%) | 10,417 (17.8%) |
| Chin | 2,217 (12.9%) | 152 (2.6%) | 2,089 (35.1%) | 2,524 (12.5%) | 1,368 (57.8%) | 8,350 (14.3%) |
| Midcheek groove | 1,517 (8.8%) | 150 (2.5%) | 849 (6.6%) | 2,128 (10.5%) | 77 (3.3%) | 4,721 (8.1%) |
| Temple | 733 (4.3%) | 53 (0.89%) | 230 (1.8%) | 1,887 (9.3%) | 59 (2.5%) | 2,962 (5.1%) |
| Periorbital puffiness | 25 (0.15%) | 2,201 (37.0%) | 24 (0.19%) | 4 (0.02%) | 2,254 (3.9%) | |
| Forehead | 356 (0.15%) | 125 (2.1%) | 544 (4.2%) | 683 (3.4%) | 11 (0.46%) | 1,719 (2.9%) |
| Lips | 35 (0.20%) | 1,551 (26.1%) | 30 (0.23%) | 14 (0.07%) | 13 (0.55%) | 1,643 (2.8%) |
| Tear trough | 82 (0.48%) | 1,107 (18.6%) | 208 (1.6%) | 176 (0.87%) | 1 (0.04%) | 1,574 (2.7%) |
| Jowls | 168 (0.98%) | 37 (0.29%) | 540 (2.7%) | 425 (18.0%) | 1,170 (2.0%) | |
| Marionette line | 53 (0.31%) | 1 (0.02%) | 152 (1.2%) | 52 (0.26%) | 6 (0.25%) | 264 (0.45%) |
| Upper eyelids | 1 (0.01%) | 235 (4.0%) | 3 (0.02%) | 2 (0.01%) | 241 (0.41%) | |
| Nose | 8 (0.05%) | 3 (0.05%) | 1 (0.01%) | 16 (0.08%) | 85 (3.6%) | 113 (0.19%) |
| Lateral Orbital | 2 (0.01%) | 15 (0.25%) | 1 (0.01%) | 5 (0.02%) | 23 (0.04%) | |
| Eyebrow tail | 7 (0.04%) | 1 (0.02%) | 8 (0.04%) | 16 (0.03%) | ||
| Hand | 2 (0.01%) | 3 (0.05%) | 6 (0.05%) | 2 (0.01%) | 13 (0.02%) | |
| Neck | 1 (0.01%) | 4 (0.07%) | 1 (0.005%) | 6 (0.01%) | ||
| TOTAL | 17,172 | 5,948 | 12,870 | 20,177 | 2,366 | 58,533 |
| . | Filler . | |||||
|---|---|---|---|---|---|---|
| Injection site . | Juvéderm Vista Ultra Plus XC . | Juvéderm Vista Volbella XC . | Juvéderm Vista Volift XC . | Juvéderm Vista Voluma XC . | Juvéderm Vista Volux XC . | TOTAL (sites) . |
| Nasolabial fold | 9,422 (54.9%) | 283 (4.8%) | 7,404 (57.5%) | 5,900 (29.2%) | 38 (1.6%) | 23,047 (39.4%) |
| Cheek | 2,543 (14.8%) | 64 (1.1%) | 1,292 (10.0%) | 6,235 (30.9%) | 283 (12.0%) | 10,417 (17.8%) |
| Chin | 2,217 (12.9%) | 152 (2.6%) | 2,089 (35.1%) | 2,524 (12.5%) | 1,368 (57.8%) | 8,350 (14.3%) |
| Midcheek groove | 1,517 (8.8%) | 150 (2.5%) | 849 (6.6%) | 2,128 (10.5%) | 77 (3.3%) | 4,721 (8.1%) |
| Temple | 733 (4.3%) | 53 (0.89%) | 230 (1.8%) | 1,887 (9.3%) | 59 (2.5%) | 2,962 (5.1%) |
| Periorbital puffiness | 25 (0.15%) | 2,201 (37.0%) | 24 (0.19%) | 4 (0.02%) | 2,254 (3.9%) | |
| Forehead | 356 (0.15%) | 125 (2.1%) | 544 (4.2%) | 683 (3.4%) | 11 (0.46%) | 1,719 (2.9%) |
| Lips | 35 (0.20%) | 1,551 (26.1%) | 30 (0.23%) | 14 (0.07%) | 13 (0.55%) | 1,643 (2.8%) |
| Tear trough | 82 (0.48%) | 1,107 (18.6%) | 208 (1.6%) | 176 (0.87%) | 1 (0.04%) | 1,574 (2.7%) |
| Jowls | 168 (0.98%) | 37 (0.29%) | 540 (2.7%) | 425 (18.0%) | 1,170 (2.0%) | |
| Marionette line | 53 (0.31%) | 1 (0.02%) | 152 (1.2%) | 52 (0.26%) | 6 (0.25%) | 264 (0.45%) |
| Upper eyelids | 1 (0.01%) | 235 (4.0%) | 3 (0.02%) | 2 (0.01%) | 241 (0.41%) | |
| Nose | 8 (0.05%) | 3 (0.05%) | 1 (0.01%) | 16 (0.08%) | 85 (3.6%) | 113 (0.19%) |
| Lateral Orbital | 2 (0.01%) | 15 (0.25%) | 1 (0.01%) | 5 (0.02%) | 23 (0.04%) | |
| Eyebrow tail | 7 (0.04%) | 1 (0.02%) | 8 (0.04%) | 16 (0.03%) | ||
| Hand | 2 (0.01%) | 3 (0.05%) | 6 (0.05%) | 2 (0.01%) | 13 (0.02%) | |
| Neck | 1 (0.01%) | 4 (0.07%) | 1 (0.005%) | 6 (0.01%) | ||
| TOTAL | 17,172 | 5,948 | 12,870 | 20,177 | 2,366 | 58,533 |
Filler Brand Distribution (Number of Injection Sites) of the 41,775 Cases (58,533 Sites) Treated With Hyaluronic Acid Filler Injection
| . | Filler . | |||||
|---|---|---|---|---|---|---|
| Injection site . | Juvéderm Vista Ultra Plus XC . | Juvéderm Vista Volbella XC . | Juvéderm Vista Volift XC . | Juvéderm Vista Voluma XC . | Juvéderm Vista Volux XC . | TOTAL (sites) . |
| Nasolabial fold | 9,422 (54.9%) | 283 (4.8%) | 7,404 (57.5%) | 5,900 (29.2%) | 38 (1.6%) | 23,047 (39.4%) |
| Cheek | 2,543 (14.8%) | 64 (1.1%) | 1,292 (10.0%) | 6,235 (30.9%) | 283 (12.0%) | 10,417 (17.8%) |
| Chin | 2,217 (12.9%) | 152 (2.6%) | 2,089 (35.1%) | 2,524 (12.5%) | 1,368 (57.8%) | 8,350 (14.3%) |
| Midcheek groove | 1,517 (8.8%) | 150 (2.5%) | 849 (6.6%) | 2,128 (10.5%) | 77 (3.3%) | 4,721 (8.1%) |
| Temple | 733 (4.3%) | 53 (0.89%) | 230 (1.8%) | 1,887 (9.3%) | 59 (2.5%) | 2,962 (5.1%) |
| Periorbital puffiness | 25 (0.15%) | 2,201 (37.0%) | 24 (0.19%) | 4 (0.02%) | 2,254 (3.9%) | |
| Forehead | 356 (0.15%) | 125 (2.1%) | 544 (4.2%) | 683 (3.4%) | 11 (0.46%) | 1,719 (2.9%) |
| Lips | 35 (0.20%) | 1,551 (26.1%) | 30 (0.23%) | 14 (0.07%) | 13 (0.55%) | 1,643 (2.8%) |
| Tear trough | 82 (0.48%) | 1,107 (18.6%) | 208 (1.6%) | 176 (0.87%) | 1 (0.04%) | 1,574 (2.7%) |
| Jowls | 168 (0.98%) | 37 (0.29%) | 540 (2.7%) | 425 (18.0%) | 1,170 (2.0%) | |
| Marionette line | 53 (0.31%) | 1 (0.02%) | 152 (1.2%) | 52 (0.26%) | 6 (0.25%) | 264 (0.45%) |
| Upper eyelids | 1 (0.01%) | 235 (4.0%) | 3 (0.02%) | 2 (0.01%) | 241 (0.41%) | |
| Nose | 8 (0.05%) | 3 (0.05%) | 1 (0.01%) | 16 (0.08%) | 85 (3.6%) | 113 (0.19%) |
| Lateral Orbital | 2 (0.01%) | 15 (0.25%) | 1 (0.01%) | 5 (0.02%) | 23 (0.04%) | |
| Eyebrow tail | 7 (0.04%) | 1 (0.02%) | 8 (0.04%) | 16 (0.03%) | ||
| Hand | 2 (0.01%) | 3 (0.05%) | 6 (0.05%) | 2 (0.01%) | 13 (0.02%) | |
| Neck | 1 (0.01%) | 4 (0.07%) | 1 (0.005%) | 6 (0.01%) | ||
| TOTAL | 17,172 | 5,948 | 12,870 | 20,177 | 2,366 | 58,533 |
| . | Filler . | |||||
|---|---|---|---|---|---|---|
| Injection site . | Juvéderm Vista Ultra Plus XC . | Juvéderm Vista Volbella XC . | Juvéderm Vista Volift XC . | Juvéderm Vista Voluma XC . | Juvéderm Vista Volux XC . | TOTAL (sites) . |
| Nasolabial fold | 9,422 (54.9%) | 283 (4.8%) | 7,404 (57.5%) | 5,900 (29.2%) | 38 (1.6%) | 23,047 (39.4%) |
| Cheek | 2,543 (14.8%) | 64 (1.1%) | 1,292 (10.0%) | 6,235 (30.9%) | 283 (12.0%) | 10,417 (17.8%) |
| Chin | 2,217 (12.9%) | 152 (2.6%) | 2,089 (35.1%) | 2,524 (12.5%) | 1,368 (57.8%) | 8,350 (14.3%) |
| Midcheek groove | 1,517 (8.8%) | 150 (2.5%) | 849 (6.6%) | 2,128 (10.5%) | 77 (3.3%) | 4,721 (8.1%) |
| Temple | 733 (4.3%) | 53 (0.89%) | 230 (1.8%) | 1,887 (9.3%) | 59 (2.5%) | 2,962 (5.1%) |
| Periorbital puffiness | 25 (0.15%) | 2,201 (37.0%) | 24 (0.19%) | 4 (0.02%) | 2,254 (3.9%) | |
| Forehead | 356 (0.15%) | 125 (2.1%) | 544 (4.2%) | 683 (3.4%) | 11 (0.46%) | 1,719 (2.9%) |
| Lips | 35 (0.20%) | 1,551 (26.1%) | 30 (0.23%) | 14 (0.07%) | 13 (0.55%) | 1,643 (2.8%) |
| Tear trough | 82 (0.48%) | 1,107 (18.6%) | 208 (1.6%) | 176 (0.87%) | 1 (0.04%) | 1,574 (2.7%) |
| Jowls | 168 (0.98%) | 37 (0.29%) | 540 (2.7%) | 425 (18.0%) | 1,170 (2.0%) | |
| Marionette line | 53 (0.31%) | 1 (0.02%) | 152 (1.2%) | 52 (0.26%) | 6 (0.25%) | 264 (0.45%) |
| Upper eyelids | 1 (0.01%) | 235 (4.0%) | 3 (0.02%) | 2 (0.01%) | 241 (0.41%) | |
| Nose | 8 (0.05%) | 3 (0.05%) | 1 (0.01%) | 16 (0.08%) | 85 (3.6%) | 113 (0.19%) |
| Lateral Orbital | 2 (0.01%) | 15 (0.25%) | 1 (0.01%) | 5 (0.02%) | 23 (0.04%) | |
| Eyebrow tail | 7 (0.04%) | 1 (0.02%) | 8 (0.04%) | 16 (0.03%) | ||
| Hand | 2 (0.01%) | 3 (0.05%) | 6 (0.05%) | 2 (0.01%) | 13 (0.02%) | |
| Neck | 1 (0.01%) | 4 (0.07%) | 1 (0.005%) | 6 (0.01%) | ||
| TOTAL | 17,172 | 5,948 | 12,870 | 20,177 | 2,366 | 58,533 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
